Drug Type Small molecule drug |
Synonyms ADX 10061, CEE 310, CEE-03-310 + [5] |
Target |
Mechanism D1 receptor antagonists(Dopamine D1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20N2O4 |
InChIKeyXZPSYCOYKJRHKE-MRXNPFEDSA-N |
CAS Registry128022-68-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 2 | DK | - | - |
Sleep Wake Disorders | Phase 2 | - | - | |
Sleep Wake Disorders | Phase 2 | - | - | |
Smoking Cessation | Phase 2 | US | - | |
Substance-Related Disorders | Phase 2 | US | - | - |
Tobacco Use Disorder | Phase 2 | - | - | |
Tobacco Use Disorder | Phase 2 | - | - |